AbbVie Inc.
DE ˙ XTRA ˙ US00287Y1091
188,50 € ↑0,35 (0,19%)
2026-06-04
AKTIENPREIS
SecurityDE:4AB / AbbVie Inc.
InstitutionSpirepoint Private Client, Llc
Latest Disclosed Ownership49,453 shares
Latest Disclosed Value $ 10,755,516
Spirepoint Private Client, Llc reports 3.21% increase in ownership of 4AB / AbbVie Inc.

On April 22, 2026 - Spirepoint Private Client, Llc filed a 13F-HR form disclosing ownership of 49,453 shares of AbbVie Inc. (DE:4AB) valued at $9,168,586 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 47,916 shares of AbbVie Inc.. This represents a change in shares of 3.21% during the quarter. The current value of the position is $9,321,890 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-22 2026-03-31 13F ABBVIE COM 00287Y109 49,453 1,537 3.21 10,756 -1.76 1.0230
2026-01-22 2025-12-31 13F ABBVIE COM 00287Y109 47,916 4,637 10.71 10,948 9.26 1.0464
2025-10-22 2025-09-30 13F ABBVIE COM 00287Y109 43,279 5,774 15.40 10,021 43.94 1.0536
2025-07-16 2025-06-30 13F ABBVIE COM 00287Y109 37,505 932 2.55 6,962 -9.15 0.7861
2025-04-23 2025-03-31 13F ABBVIE COM 00287Y109 36,573 1,553 4.43 7,663 23.12 1.0011
2025-01-27 2024-12-31 13F ABBVIE COM 00287Y109 35,020 4,364 14.24 6,223 2.81 0.7799
2024-11-05 2024-09-30 13F ABBVIE COM 00287Y109 30,656 706 2.36 6,054 17.83 0.8016
2024-08-08 2024-06-30 13F ABBVIE COM 00287Y109 29,950 906 3.12 5,137 -2.86 0.7282
2024-05-10 2024-03-31 13F ABBVIE COM 00287Y109 29,044 29,044 5,289 0.8055
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.